https://idataresearch.com/wp-content/uploads/2021/12/ReportIcon-Kidneys-MS.jpg

Urology Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Stone Management Devices, BPH Treatment Devices, and 7 more

Overall, the U.S. urology market was valued at over $3.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 4.3% to reach $5 billion by 2028.

As the U.S. urology market demand continues to undergo consolidation with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing organizations (GPOs) as well as reimbursement cuts across the urology space, the ASPs are expected to remain under significant pressure, negatively impacting the future growth of the market.

U.S. Urology MarketIn 2021, the largest segment of the total urological device market was urinary incontinence. Growth of this segment is primarily driven by the urinary catheter segment and the high-volume use of urinary catheters. The second-largest segment of the total urological device market in 2021 was BPH treatment devices. Growth of this segment is primarily driven by the UroLift® market, which has experienced rapid growth since NeoTract launched the UroLift® system in 2013.

MARKET REPORT DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

COVID-19 IMPACT ON THE U.S. UROLOGY MARKET

Overall, the negative impact of the COVID-19 pandemic on the urological device market seems to vary depending on the severity of each case. Erectile dysfunction (ED), benign prostate hyperplasia (BPH) and stone management treatments are elective procedures. As such, these market segments experienced the greatest decline. However, urgent treatments, as demonstrated in the prostate cancer treatment device market, were less impacted by the COVID-19 pandemic.

U.S. UROLOGY MARKET SHARE INSIGHTS

Overall, within the U.S. Urology market there are three dominant competitors: Boston Scientific, Becton Dickinson, and Coloplast.Top competitors

In 2021, the leading competitor in the urological device market was Boston Scientific. The company held the leading positions in the stone management device segment, prostate cancer device segment and men’s reproductive health segment. The company also held notable positions in all remaining segments, with the exception of the urodynamic equipment market, from which the company was absent.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

  • Urinary Incontinence Devices Market – MedCore – The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents and incontinence management devices.
  • Stone Management Devices – MedCore – The total market for stone management devices includes ESWL capital equipment, pneumatic, ultrasonic, and combination lithotripsy capital equipment, Holmium and Thulium laser capital equipment and fibers, stone fragment retrieval devices, access sheaths and ureteral stents.
  • BPH Treatment Devices – MedCore – The BPH treatment device market includes devices used for TURP, TUMT, TUNA, prostatic stent, laser BPH, UroLift®, Rez?m® and iTind® procedures. In 2021, the largest segment in the BPH treatment device market was the UroLift® market.
  • Urological Endoscope – MedCore – The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.
  • Prostate Cancer Treatment Devices – MedCore – The prostate cancer treatment device market includes brachytherapy devices and cryotherapy ablation devices.
  • Urodynamic Equipment Market – MedCore – The market for urodynamic equipment includes capital equipment and disposables. As these procedures can be performed in both hospitals and outpatient offices, the capital equipment market is segmented into those sold at hospitals versus those sold at outpatient offices.
  • Nephrostomy Devices – MedCore – The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.
  • Men’s Reproductive Health Market – MedCore – The total market for men’s reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices and vacuum assisted erectile dysfunction devices.
  • Urinary Guidewire Market – MedCore – The market for guidewires includes all guidewires to be used in urological procedures.

Research Scope Summary

Report Attribute Details
Regions United States
Base Year 2021
Forecast 2022-2028
Historical Data 2018-2021
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

FREE Sample Report

TABLE OF CONTENTS I LIST OF FIGURES  XVI LIST OF CHARTS  XXVIII EXECUTIVE SUMMARY US UROLOGICAL DEVICE MARKET OVERVIEW COMPETITIVE ANALYSIS
  • MARKET TRENDS
  • MARKET DEVELOPMENTS
  • PROCEDURE NUMBERS
  • PROCEDURE CODES INVESTIGATED
  • MARKETS INCLUDED
  • KEY REPORT UPDATES
  • VERSION HISTORY
  • RESEARCH METHODOLOGY
  • IMPACT OF COVID-19 ON THE US UROLOGICAL DEVICE MARKET
  • 21 INTRODUCTION
  • 22 ANALYSIS BY MARKET SEGMENT
  • DISEASE OVERVIEW
  • 31 BASIC ANATOMY
  • 32 DISEASE TREATMENT AND DIAGNOSTICS
  • 33 PATIENT DEMOGRAPHICS
  • PRODUCT ASSESSMENT
  • INTRODUCTION
  • 42 PRODUCT PORTFOLIOS
  • 43 REGULATORY ISSUES AND RECALLS
  • US UROLOGICAL DEVICE MARKET OVERVIEW
  • 51 MARKET OVERVIEW & TREND ANALYSIS
  • 52 DRIVERS AND LIMITERS
  • 53 COMPETITIVE MARKET SHARE ANALYSIS
  • 54 MERGERS AND ACQUISITIONS
  • 55 COMPANY PROFILES
  • PROCEDURE NUMBERS
  • 61 PROCEDURE CODES INVESTIGATED
  • 62 PROCEDURE OVERVIEW
  • URINARY INCONTINENCE DEVICE MARKET
  • 71 INTRODUCTION
  • 72 MARKET OVERVIEW
  • 73 MARKET ANALYSIS AND FORECAST
  • 74 DRIVERS AND LIMITERS
  • 75 COMPETITIVE MARKET SHARE ANALYSIS
  • STONE MANAGEMENT DEVICE MARKET
  • 81 INTRODUCTION
  • 82 MARKET OVERVIEW
  • 83 MARKET ANALYSIS AND FORECAST
  • 84 DRIVERS AND LIMITERS
  • 85 COMPETITIVE MARKET SHARE ANALYSIS
  • BPH TREATMENT DEVICE MARKET
  • 91 INTRODUCTION
  • 92 MARKET OVERVIEW
  • 93 MARKET ANALYSIS AND FORECAST
  • 94 DRIVERS AND LIMITERS
  • 95 COMPETITIVE MARKET SHARE ANALYSIS
  • UROLOGICAL ENDOSCOPE MARKET
  • 101 INTRODUCTION
  • 102 MARKET OVERVIEW
  • 103 MARKET ANALYSIS AND FORECAST
  • 104 DRIVERS AND LIMITERS
  • 105 COMPETITIVE MARKET SHARE ANALYSIS
  • PROSTATE CANCER TREATMENT DEVICE MARKET
  • 111 INTRODUCTION
  • 112 MARKET OVERVIEW
  • 113 MARKET ANALYSIS AND FORECAST
  • 114 DRIVERS AND LIMITERS
  • 115 COMPETITIVE MARKET SHARE ANALYSIS
  • URODYNAMIC EQUIPMENT MARKET
  • 121 INTRODUCTION
  • 122 MARKET OVERVIEW
  • 123 MARKET ANALYSIS AND FORECAST
  • 124 DRIVERS AND LIMITERS
  • 125 COMPETITIVE MARKET SHARE ANALYSIS
  • NEPHROSTOMY DEVICE MARKET
  • 131 INTRODUCTION
  • 132 MARKET OVERVIEW
  • 133 MARKET ANALYSIS AND FORECAST
  • 134 DRIVERS AND LIMITERS
  • 135 COMPETITIVE MARKET SHARE ANALYSIS
  • MEN’S REPRODUCTIVE HEALTH MARKET
  • 141 INTRODUCTION
  • 142 MARKET OVERVIEW
  • 143 MARKET ANALYSIS AND FORECAST
  • 144 DRIVERS AND LIMITERS
  • 145 COMPETITIVE MARKET SHARE ANALYSIS
  • URINARY GUIDEWIRE MARKET
  • 151 INTRODUCTION
  • 152 MARKET ANALYSIS AND FORECAST
  • 153 DRIVERS AND LIMITERS
  • 154 COMPETITIVE MARKET SHARE ANALYSIS
  • ABBREVIATIONS
  • LIST OF FIGURES
LIST OF CHARTS
  • Chart 1-1: Urological Device Market by Segment, US, 2021 – 2028
  • Chart 1-2: Urological Device Market Overview, US, 2021 & 2028
  • Chart 2-1: Multi-Scenario Urological Device Market Forecast, US, 2018 – 2028 (US$M)
  • Chart 5-1: Urological Device Market by Segment, US, 2018 – 2028
  • Chart 5-2: Leading Competitors, Urological Device Market, US, 2021
  • Chart 6-1: Urology Market Procedures by Segment, US, 2018 – 2028
  • Chart 7-1: Urinary Incontinence Device Market by Segment, US, 2018 – 2028
  • Chart 8-1: Stone Management Device Market by Segment, US, 2018 – 2028
  • Chart 8-2: Leading Competitors, Stone Management Device Market, US, 2021
  • Chart 9-1: BPH Treatment Device Market by Segment, US, 2018 – 2028
  • Chart 9-2: Leading Competitors, BPH Treatment Device Market, US, 2021
  • Chart 10-1: Urological Endoscope Market by Segment, US, 2018 – 2028
  • Chart 10-2: Urological Endoscope Market by Condition, US, 2018 – 2028
  • Chart 10-3: Leading Competitors, Urological Endoscope Market, US, 2021
  • Chart 11-1: Prostate Cancer Treatment Device Market by Segment, US, 2018 – 2028
  • Chart 11-2: Leading Competitors, Prostate Cancer Treatment Device Market, US, 2021
  • Chart 11-1: Leading Competitors, Brachytherapy Device Market, US, 2021
  • Chart 12-1: Urodynamic Equipment Market by Segment, US, 2018 – 2028
  • Chart 12-2: Leading Competitors, Urodynamic Equipment Market, US, 2021
  • Chart 13-1: Nephrostomy Device Market by Segment, US, 2018 – 2028
  • Chart 13-2: Leading Competitors, Nephrostomy Device Market, US, 2021
  • Chart 14-1: Men’s Reproductive Health Market by Segment, US, 2018 – 2028
  • Chart 14-2: Leading Competitors, Men’s Reproductive Health Market, US, 2021
  • Chart 15-1: Urinary Guidewire Market, US, 2018 – 2028
  • Chart 15-2: Leading Competitors, Urinary Guidewire Market, US, 2021
LIST OF FIGURES
  • Figure 1-1: Urological Device Market Share Ranking by Segment, US, 2021 (1 of 2)
  • Figure 1-2: Urological Device Market Share Ranking by Segment, US, 2021 (2 of 2)
  • Figure 1-3: Companies Researched in this Report (1 of 2)
  • Figure 1-4: Companies Researched in this Report (2 of 2)
  • Figure 1-5: Factors Impacting the Urological Device Market by Segment, US (1 of 2)
  • Figure 1-6: Factors Impacting the Urological Device Market by Segment, US (2 of 2)
  • Figure 1-7: Recent Events in the Urological Device Market, US, 2018 – 2021
  • Figure 1-8: Urological Device Procedures Covered (1 of 2)
  • Figure 1-9: Urological Device Procedures Covered (2 of 2)
  • Figure 1-10: Procedure Codes Investigated
  • Figure 1-11: Urological Device Markets Covered (1 of 5)
  • Figure 1-12: Urological Device Markets Covered (2 of 5)
  • Figure 1-13: Urological Device Markets Covered (3 of 5)
  • Figure 1-14: Urological Device Markets Covered (4 of 5)
  • Figure 1-15: Urological Device Markets Covered (5 of 5)
  • Figure 1-16: Key Report Updates
  • Figure 1-17: Version History
  • Figure 2-1: Urological Device Market by Segment, Worst Case Scenario, US, 2018 – 2028 (US$M) (1 of 2)
  • Figure 2-2: Urological Device Market by Segment, Worst Case Scenario, US, 2018 – 2028 (US$M) (2 of 2)
  • Figure 2-3: Urological Device Market by Segment, Base Case Scenario, US, 2018 – 2028 (US$M) (1 of 2)
  • Figure 2-4: Urological Device Market by Segment, Base Case Scenario, US, 2018 – 2028 (US$M) (2 of 2)
  • Figure 2-5: Urological Device Market by Segment, Best Case Scenario, US, 2018 – 2028 (US$M) (1 of 2)
  • Figure 2-6: Urological Device Market by Segment, Best Case Scenario, US, 2018 – 2028 (US$M) (2 of 2)
  • Figure 4-1: Urinary Incontinence Treatments by Company (1 of 3)
  • Figure 4-2: Urinary Incontinence Treatments by Company (2 of 3)
  • Figure 4-3: Urinary Incontinence Treatments by Company (3 of 3)
  • Figure 4-4: Stone Management Devices by Company (1 of 3)
  • Figure 4-5: Stone Management Devices by Company (2 of 3)
  • Figure 4-6: Stone Management Devices by Company (3 of 3)
  • Figure 4-7: BPH Treatments by Company
  • Figure 4-8: Urological Endoscopes by Company (1 of 2)
  • Figure 4-9: Urological Endoscopes by Company (2 of 2)
  • Figure 4-10: Prostate Cancer Treatments by Company
  • Figure 4-11: Urodynamic Equipment and Consumables by Company
  • Figure 4-12: Nephrostomy Devices by Company
  • Figure 4-13: Men’s Reproductive Health Devices by Company
  • Figure 4-14: Testicular Implants by Company
  • Figure 4-15: Urinary Guidewires by Company
  • Figure 4-16: Class 2 Device Recall Magic 3 Intermittent Catheters
  • Figure 4-17: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter
  • Figure 4-18: Class 2 Device Recall Bard Magic 3 Antibacterial Hydrophilic Intermittent Catheter
  • Figure 4-19: Class 2 Device Recall SureStep
  • Figure 4-20: Class 2 Device Recall AMS 800 Artificial Urinary Sphincter AMS 800 Belt Cuff
  • Figure 4-21: Class 2 Device Recall AMS 700 100 mL Spherical Reservoir with InhibiZone
  • Figure 4-22: Class 2 Device Recall Uphold LITE w/ Capio SLIM
  • Figure 4-23: Class 2 Device Recall Stretch VL Ureteral Stent Set
  • Figure 4-24: Class 2 Device Recall Contour VL Ureteral Stent Set
  • Figure 4-25: Class 2 Device Recall Auriga 30 Laser System
  • Figure 4-26: Class 2 Device Recall AURIGA 30 BRAZIL ZERO COST SYSTEM
  • Figure 4-27: Class 2 Device Recall MoXy Laser Fiber
  • Figure 4-28: Class 2 Device Recall IcePearl 21 CX 90 Cyroablation Needles
  • Figure 4-29: Class 2 Device Recall IceSphere" Cryoablation Needles
  • Figure 4-30: Class 2 Device Recall Titan Pump
  • Figure 4-31: Class 2 Device Recall Dornier
  • Figure 4-32: Class 2 Device Recall Visual ICE Cryoablation System
  • Figure 4-33: Class 2 Device Recall Ureteroreno videoscope URFV2; Ureteroreno videoscope URFV2R
  • Figure 4-34: Class 3 Device Recall RUSCH Urinary Drainage bag
  • Figure 4-35: Class 2 Device Recall Rusch EasyCath Kit
  • Figure 4-36: Class 3 Device Recall Teleflex MEDICAL RuSCH One piece Male External Medium Catheter
  • W/O Tape
  • Figure 4-37: Artificial Urinary Sphincter Clinical Outcomes (AUSCO)
  • Figure 4-38: Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally
  • Invasive Sacrocolpopexy (SASS)
  • Figure 4-39: Double-J PLUS Postmarket Registry
  • Figure 4-40: Rezum I Pilot Study for Benign Prostatic Hyperplasia (Rezum Pilot)
  • Figure 4-41: Rezum FIM Optimization Study (Rezum FIM)
  • Figure 4-42: To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH
  • Treatment in China
  • Figure 4-43: To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients
  • With Urinary Disease (LithoVue)
  • Figure 4-44: Investigation of New Intermittent Catheters in Healthy Volunteers
  • Figure 4-45: Exploratory Study of a New Urine Collection Device for Men
  • Figure 4-46: Investigation of Non-CE Marked Intermittent Catheters for Females
  • Figure 4-47: T-DOC® 5 Fr Pediatric Clinical Investigation
  • Figure 4-48: T-DOC® NXT Clinical Investigation
  • Figure 4-49: e۰Sense® Catheter Clinical Investigation
  • Figure 4-50: T-DOC® 5 Fr Pediatric Clinical Investigation
  • Figure 4-51: Study of Median Lobe Prostatic UroLift Procedure
  • Figure 4-52: Urodynamic Feasibility Study Utilizing the UroLift® System (UDS)
  • Figure 4-53: Comparing UroLift Experience Against Rezūm (CLEAR)
  • Figure 4-54: ARTUS MONO Artificial Urinary Sphincter
  • Figure 4-55: Safety and Efficacy Study of USTRAP™ in Male Urinary Incontinence (PROSPECT)
  • Figure 4-56: Connected Catheter- Safety and Effectiveness Study
  • Figure 4-57: Evaluation of a New Female Urinary Intermittent Catheter
  • Figure 4-58: Post-Market Clinical Follow-Up onTVT EXACT® Continence System
  • Figure 4-59: A Study of the PedSCath Pediatric Sampling Catheter Versus Current Standard of Care
  • Figure 4-60: Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent
  • Following Uncomplicated Ureteroscopy (URIPRENE)
  • Figure 4-61: The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil
  • Bladder Position
  • Figure 4-62: Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder
  • Figure 4-63: Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for
  • Flexible Cystoscopy
  • Figure 4-64: LDR vs HDR Brachytherapy for Prostate Cancer (LDR/HDRmono)
  • Figure 4-65: Urodynamic Assessment of the Lower Urinary Tract: Water vs Air - Synchrony
  • Figure 5-1: Urological Device Market by Segment, US, 2018 – 2028 (US$M) (1 of 2)
  • Figure 5-2: Urological Device Market by Segment, US, 2018 – 2028 (US$M) (2 of 2)
  • Figure 5-3: Leading Competitors, Urological Device Market, US, 2021 (1 of 2)
  • Figure 5-4: Leading Competitors, Urological Device Market, US, 2021 (2 of 2)
  • Figure 5-5: SWOT Analysis, Becton Dickinson
  • Figure 5-6: SWOT Analysis, Boston Scientific
  • Figure 5-7: SWOT Analysis, Cardinal Health
  • Figure 5-8: SWOT Analysis, Coloplast
  • Figure 5-9: SWOT Analysis, Cook Medical
  • Figure 5-10: SWOT Analysis, Elekta
  • Figure 5-11: SWOT Analysis, Karl Storz
  • Figure 5-12: SWOT Analysis, LABORIE
  • Figure 5-13: SWOT Analysis, Lumenis
  • Figure 5-14: SWOT Analysis, Olympus
  • Figure 5-15: SWOT Analysis, Teleflex
  • Figure 6-1: Procedure Codes Investigated, US, 2021
  • Figure 6-2: Urological Procedures by Segment, US, 2018 – 2028
  • Figure 6-3: Urinary Incontinence Management Procedures by Segment, US, 2018 – 2028
  • Figure 6-4: Male Urinary Incontinence Management Procedures by Segment, US, 2018 – 2028
  • Figure 6-5: Female Urinary Incontinence Management Procedures by Segment, US, 2018 – 2028
  • Figure 6-6: Stone Management Procedures by Segment, US, 2018 – 2028
  • Figure 6-7: ESWL Procedures, US, 2018 – 2028
  • Figure 6-8: Transurethral Procedures by Segment, US, 2018 – 2028
  • Figure 6-9: Ureteral Stent Procedures, US, 2018 – 2028
  • Figure 6-10: PCNL Procedures, US, 2018 – 2028
  • Figure 6-11: BPH Patient Statistics, US, 2018 – 2028
  • Figure 6-12: BPH Procedures by Segment, US, 2018 – 2028 (1 of 2)
  • Figure 6-13: BPH Procedures by Segment, US, 2018 – 2028 (2 of 2)
  • Figure 6-14: BPH Patient Statistics, US, 2018 – 2028
  • Figure 6-15: Prostate Cancer Treatment Procedures by Segment, US, 2018 – 2028
  • Figure 6-16: Watchful Waiting Procedures, US, 2018 – 2028
  • Figure 6-17: Prostatectomy Procedures by Segment, US, 2018 – 2028
  • Figure 6-18: Open Prostatectomy Procedures by Segment, US, 2018 – 2028
  • Figure 6-19: Ablation Procedures by Segment, US, 2018 – 2028
  • Figure 6-20: Radiation Therapy Procedures by Segment, US, 2018 – 2028
  • Figure 6-21: HDR Brachytherapy Procedures by Segment, US, 2018 – 2028
  • Figure 6-22: LDR Brachytherapy Procedures by Segment, US, 2018 – 2028
  • Figure 6-23: External Radiation Therapy Procedures by Segment, US, 2018 – 2028
  • Figure 6-24: Urodynamic Testing Procedures by Segment, US, 2018 – 2028
  • Figure 6-25: Cystometrogram Procedures by Segment, US, 2018 – 2028
  • Figure 6-26: Uroflowmetry Procedures by Segment, US, 2018 – 2028
  • Figure 6-27: Nephrostomy Procedures by Segment, US, 2018 – 2028
  • Figure 6-28: Erectile Dysfunction Management Procedures by Segment, US, 2018 – 2028
  • Figure 7-1: Urinary Incontinence Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-2: Urinary Catheter Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-3: Intermittent Catheter Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-4: Total Intermittent Catheter Market, US, 2018 – 2028
  • Figure 7-5: Coated Intermittent Catheter Market, US, 2018 – 2028
  • Figure 7-6: Uncoated Intermittent Catheter Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-7: Uncoated Latex-Free Intermittent Catheter Market, US, 2018 – 2028
  • Figure 7-8: Uncoated Latex Intermittent Catheter Market, US, 2018 – 2028
  • Figure 7-9: Closed System Intermittent Catheter Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-10: Gel Closed System Intermittent Catheter Market, US, 2018 – 2028
  • Figure 7-11: Hydrophilic and Antimicrobial Closed System Intermittent Catheter Market, US, 2018 –
  • 2028
  • Figure 7-12: Foley Catheter Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-13: Total Foley Catheter Market, US, 2018 – 2028
  • Figure 7-14: Latex Foley Catheter Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-15: Total Latex Foley Catheter Market, US, 2018 – 2028
  • Figure 7-16: Uncoated Latex Foley Catheter Market, US, 2018 – 2028
  • Figure 7-17: Coated Latex Foley Catheter Market, US, 2018 – 2028
  • Figure 7-18: Latex-Free Foley Catheter Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-19: Total Latex-Free Foley Catheter Market, US, 2018 – 2028
  • Figure 7-20: Uncoated Latex-Free Foley Catheter Market, US, 2018 – 2028
  • Figure 7-21: Coated Latex-Free Foley Catheter Market, US, 2018 – 2028
  • Figure 7-22: Closed System Foley Tray Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-23: Total Closed System Foley Tray Market, US, 2018 – 2028
  • Figure 7-24: Conventional Closed System Foley Tray Market, US, 2018 – 2028
  • Figure 7-25: Antimicrobial Closed System Foley Tray Market, US, 2018 – 2028
  • Figure 7-26: External Catheter Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-27: Total External Catheter Market, US, 2018 – 2028
  • Figure 7-28: Male External Catheter Market, US, 2018 – 2028
  • Figure 7-29: Female External Catheter Market, US, 2018 – 2028
  • Figure 7-30: Urethral Bulking Agent Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-31: Total Urethral Bulking Agent Market, US, 2018 – 2028
  • Figure 7-32: Male Urethral Bulking Agent Market, US, 2018 – 2028
  • Figure 7-33: Female Urethral Bulking Agent Market, US, 2018 – 2028
  • Figure 7-34: Incontinence Management Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-35: Total Incontinence Management Device Market, US, 2018 – 2028
  • Figure 7-36: Female Incontinence Sling Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-37: Total Female Incontinence Sling Market, US, 2018 – 2028
  • Figure 7-38: Transvaginal Tape Female Incontinence Sling Market, US, 2018 – 2028
  • Figure 7-39: Transobturator Female Incontinence Sling Market, US, 2018 – 2028
  • Figure 7-40: Single-Incision Female Incontinence Sling Market, US, 2018 – 2028
  • Figure 7-41: Male Implantable Incontinence Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-42: Total Male Implantable Incontinence Device Market, US, 2018 – 2028
  • Figure 7-43: Male Incontinence Sling Market, US, 2018 – 2028
  • Figure 7-44: Male Artificial Urinary Sphincter Market, US, 2018 – 2028
  • Figure 7-45: Urinary Bag Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 7-46: Total Urinary Bag Market, US, 2018 – 2028
  • Figure 7-47: Bedside Urine Drainage Bag Market, US, 2018 – 2028
  • Figure 7-48: Leg Urine Drainage Bag Market, US, 2018 – 2028
  • Figure 7-49: Leading Competitors, Urinary Incontinence Device Market, US, 2021
  • Figure 7-50: Leading Competitors, Urinary Catheter Market, US, 2021
  • Figure 7-51: Leading Competitors, Incontinence Management Device Market, US, 2021
  • Figure 8-1: Stone Management Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 8-2: ESWL Equipment Market, US, 2018 – 2028
  • Figure 8-3: ISWL Equipment Market, US, 2018 – 2028
  • Figure 8-4: Holmium Laser Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 8-5: Holmium Laser Equipment Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 8-6: Total Holmium Laser Equipment Market, US, 2018 – 2028
  • Figure 8-7: Medium Power Holmium Laser Equipment Market, US, 2018 – 2028
  • Figure 8-8: Low Power Holmium Laser Equipment Market, US, 2018 – 2028
  • Figure 8-9: Holmium Laser Fiber Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 8-10: Total Holmium Laser Fiber Market, US, 2018 – 2028
  • Figure 8-11: Reusable Holmium Laser Fiber Market, US, 2018 – 2028
  • Figure 8-12: Single-Use Holmium Laser Fiber Market, US, 2018 – 2028
  • Figure 8-13: Thulium Laser Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 8-14: Thulium Laser Equipment Market, US, 2018 – 2028
  • Figure 8-15: Thulium Laser Fiber Market, US, 2018 – 2028
  • Figure 8-16: Stone Fragment Retrieval Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 8-17: Total Stone Fragment Retrieval Device Market, US, 2018 – 2028
  • Figure 8-18: Nitinol Stone Fragment Retrieval Device Market, US, 2018 – 2028
  • Figure 8-19: Stainless Steel Stone Fragment Retrieval Device Market, US, 2018 – 2028
  • Figure 8-20: Ureteral Stent Market, US, 2018 – 2028
  • Figure 8-21: Access Sheath Market Stent Market, US, 2018 – 2028
  • Figure 8-22: Leading Competitors, Stone Management Device Market, US, 2021
  • Figure 9-1: BPH Treatment Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-2: TURP Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-3: Monopolar Electrode Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-4: Total Monopolar Electrode Market, US, 2018 – 2028
  • Figure 9-5: Monopolar Electrode Loop Market, US, 2018 – 2028
  • Figure 9-6: Monopolar Coagulating Resector Electrode Market, US, 2018 – 2028
  • Figure 9-7: Monopolar Vaporizing Electrode Market, US, 2018 – 2028
  • Figure 9-8: Other Monopolar Electrode Device Market, US, 2018 – 2028
  • Figure 9-9: Bipolar Electrode Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-10: Total Bipolar Electrode Market, US, 2018 – 2028
  • Figure 9-11: Bipolar Electrode Loop Market, US, 2018 – 2028
  • Figure 9-12: Bipolar Vaporizing Electrode Market, US, 2018 – 2028
  • Figure 9-13: Other Bipolar Electrode Device Market, US, 2018 – 2028
  • Figure 9-14: TUMT Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-15: TUMT Equipment Market, US, 2018 – 2028
  • Figure 9-16: TUMT Consumables Market, US, 2018 – 2028
  • Figure 9-17: TUNA Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-18: TUNA Equipment Market, US, 2018 – 2028
  • Figure 9-19: TUNA Consumables Market, US, 2018 – 2028
  • Figure 9-20: Temporary Prostatic Stent Market, US, 2018 – 2028
  • Figure 9-21: Laser BPH Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-22: Total Laser BPH Equipment Market, US, 2018 – 2028
  • Figure 9-23: Laser BPH Equipment Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-24: Total High Power Holmium Laser Equipment Market, US, 2018 – 2028
  • Figure 9-25: Thulium Laser Equipment Market, US, 2018 – 2028
  • Figure 9-26: Total Laser BPH Fiber Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-27: Total Laser BPH Fiber Market, US, 2018 – 2028
  • Figure 9-28: Total Water Targeting Fiber Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-29: Total Water Target Laser BPH Fiber Market, US, 2018 – 2028
  • Figure 9-30: Holmium BPH Fiber Market, US, 2018 – 2028
  • Figure 9-31: Thulium BPH Fiber Market, US, 2018 – 2028
  • Figure 9-32: Total Hemoglobin Target Laser BPH Fiber Market, US, 2018 – 2028
  • Figure 9-33: UroLift Market, US, 2018 – 2028
  • Figure 9-34: Total Rezūm® Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 9-35: Rezūm® Equipment Market, US, 2018 – 2028
  • Figure 9-36: Rezūm® Consumables Market, US, 2018 – 2028
  • Figure 9-37: iTind Market, US, 2018 – 2028
  • Figure 9-38: Leading Competitors, BPH Treatment Device Market, US, 2021
  • Figure 10-1: Urological Endoscope Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 10-2: Urological Endoscope Market by Condition, US, 2018 – 2028 (US$M)
  • Figure 10-3: Urological Endoscope Market, US, 2018 – 2028
  • Figure 10-4: Cystoscope Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 10-5: Total Cystoscope Market, US, 2018 – 2028
  • Figure 10-6: Single-Use Cystoscope Market, US, 2018 – 2028
  • Figure 10-7: Reusable Cystoscope Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 10-8: Total Reusable Cystoscope Market, US, 2018 – 2028
  • Figure 10-9: Reusable Rigid Cystoscope Market by Condition, US, 2018 – 2028 (US$M)
  • Figure 10-10: Total Reusable Rigid Cystoscope Market, US, 2018 – 2028
  • Figure 10-11: New Rigid Cystoscope Market, US, 2018 – 2028
  • Figure 10-12: Refurbished Rigid Cystoscope Market, US, 2018 – 2028
  • Figure 10-13: Reusable Flexible Cystoscope Market by Condition, US, 2018 – 2028 (US$M)
  • Figure 10-14: Total Reusable Flexible Cystoscope Market, US, 2018 – 2028
  • Figure 10-15: New Flexible Cystoscope Market by Type, US, 2018 – 2028 (US$M)
  • Figure 10-16: Total New Flexible Cystoscope Market, US, 2018 – 2028
  • Figure 10-17: New Flexible Fiber Optic Cystoscope Market, US, 2018 – 2028
  • Figure 10-18: New Flexible Digital Cystoscope Market, US, 2018 – 2028
  • Figure 10-19: Reusable Refurbished Flexible Cystoscope Market by Type, US, 2018 – 2028 (US$M)
  • Figure 10-20: Total Refurbished Flexible Cystoscope Market, US, 2018 – 2028
  • Figure 10-21: Refurbished Flexible Fiber Optic Cystoscope Market, US, 2018 – 2028
  • Figure 10-22: Refurbished Flexible Digital Cystoscope Market, US, 2018 – 2028
  • Figure 10-23: Ureteroscope Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 10-24: Total Ureteroscope Market, US, 2018 – 2028
  • Figure 10-25: Single-Use Flexible Ureteroscope Market, US, 2018 – 2028
  • Figure 10-26: Reusable Ureteroscope Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 10-27: Total Reusable Ureteroscope Market, US, 2018 – 2028
  • Figure 10-28: Reusable Semi-Rigid Ureteroscope Market by Condition, US, 2018 – 2028 (US$M)
  • Figure 10-29: Total Reusable Semi-Rigid Ureteroscope Market, US, 2018 – 2028
  • Figure 10-30: New Semi-Rigid Ureteroscope Market, US, 2018 – 2028
  • Figure 10-31: Refurbished Semi-Rigid Ureteroscope Market, US, 2018 – 2028
  • Figure 10-32: Reusable Flexible Ureteroscope Market by Condition, US, 2018 – 2028 (US$M)
  • Figure 10-33: Total Reusable Flexible Ureteroscope Market, US, 2018 – 2028
  • Figure 10-34: New Flexible Ureteroscope Market by Type, US, 2018 – 2028 (US$M)
  • Figure 10-35: Total New Flexible Ureteroscope Market, US, 2018 – 2028
  • Figure 10-36: New Flexible Fiber Optic Ureteroscope Market, US, 2018 – 2028
  • Figure 10-37: New Flexible Digital Ureteroscope Market, US, 2018 – 2028
  • Figure 10-38: Reusable Refurbished Flexible Ureteroscope Market by Type, US, 2018 – 2028 (US$M)
  • Figure 10-39: Total Refurbished Flexible Ureteroscope Market, US, 2018 – 2028
  • Figure 10-40: Refurbished Flexible Fiber Optic Ureteroscope Market, US, 2018 – 2028
  • Figure 10-41: Refurbished Flexible Digital Ureteroscope Market, US, 2018 – 2028
  • Figure 10-42: Resectoscope Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 10-43: Total Resectoscope Market, US, 2018 – 2028
  • Figure 10-44: New Resectoscope Market, US, 2018 – 2028
  • Figure 10-45: Refurbished Resectoscope Market, US, 2018 – 2028
  • Figure 10-46: Nephroscope Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 10-47: Total Nephroscope Market, US, 2018 – 2028
  • Figure 10-48: New Nephroscope Market, US, 2018 – 2028
  • Figure 10-49: Refurbished Nephroscope Market, US, 2018 – 2028
  • Figure 10-50: Leading Competitors, Urological Endoscope Market, US, 2021
  • Figure 11-1: Prostate Cancer Treatment Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 11-2: Brachytherapy Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 11-3: HDR Brachytherapy Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 11-4: Afterloader Market, US, 2018 – 2028
  • Figure 11-5: Afterloader Service Market, US, 2018 – 2028
  • Figure 11-6: LDR Brachytherapy Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 11-7: LDR Seed Market by Isotope, US, 2018 – 2028 (US$M)
  • Figure 11-8: LDR Seed Market by Seed Type, US, 2018 – 2028 (US$M)
  • Figure 11-9: Total LDR Seed Market, US, 2018 – 2028
  • Figure 11-10: Cs-131 Market by Seed Type, US, 2018 – 2028 (US$M)
  • Figure 11-11: Total Cs-131 Market, US, 2018 – 2028
  • Figure 11-12: Stranded Cs-131 Market, US, 2018 – 2028
  • Figure 11-13: Non-Stranded Cs-131 Market, US, 2018 – 2028
  • Figure 11-14: Pd-103 Market by Seed Type, US, 2018 – 2028 (US$M)
  • Figure 11-15: Total Pd-103 Market, US, 2018 – 2028
  • Figure 11-16: Stranded Pd-103 Market, US, 2018 – 2028
  • Figure 11-17: Non-Stranded Pd-103 Market, US, 2018 – 2028
  • Figure 11-18: I-125 Market by Seed Type, US, 2018 – 2028 (US$M)
  • Figure 11-19: Total I-125 Market, US, 2018 – 2028
  • Figure 11-20: Stranded I-125 Market, US, 2018 – 2028
  • Figure 11-21: Non-Stranded I-125 Market, US, 2018 – 2028
  • Figure 11-22: LDR Needle Market, US, 2018 – 2028
  • Figure 11-23: Cryotherapy Ablation Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 11-24: Cryotherapy Ablation Device Market, US, 2018 – 2028
  • Figure 11-25: Cryotherapy Ablation Device Rental Market, US, 2018 – 2028
  • Figure 11-26: Cryotherapy Ablation Probe Market, US, 2018 – 2028
  • Figure 11-27: Hydrogel Rectal Spacer Device Market, US, 2018 – 2028
  • Figure 11-28: Leading Competitors, Prostate Cancer Treatment Device Market, US, 2021
  • Figure 11-29: Leading Competitors, Brachytherapy Device Market, US, 2021
  • Figure 12-1: Urodynamic Equipment Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 12-2: Urodynamic Equipment Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 12-3: Total Urodynamic Equipment Market, US, 2018 – 2028
  • Figure 12-4: Hospital Urodynamic Capital Equipment Market, US, 2018 – 2028
  • Figure 12-5: Medical Office Urodynamic Capital Equipment Market, US, 2018 – 2028
  • Figure 12-6: Total Urodynamic Consumables Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 12-7: Total Urodynamic Consumables Market, US, 2018 – 2028
  • Figure 12-8: Air-Charged Catheter Market, US, 2018 – 2028
  • Figure 12-9: Water-Filled Catheter Market, US, 2018 – 2028
  • Figure 12-10: Fiber Optic Catheter Market, US, 2018 – 2028
  • Figure 12-11: Leading Competitors, Urodynamic Equipment Market, US, 2021
  • Figure 13-1: Nephrostomy Device Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 13-2: Percutaneous Nephrostomy Set Market, US, 2018 – 2028
  • Figure 13-3: Nephrostomy Balloon Catheter Market, US, 2018 – 2028
  • Figure 13-4: Nephrostomy Drainage Tube Market, US, 2018 – 2028
  • Figure 13-5: Leading Competitors, Nephrostomy Device Market, US, 2021
  • Figure 14-1: Men’s Reproductive Health Market by Segment, US, 2018 – 2028 (US$M)
  • Figure 14-2: Inflatable Erectile Dysfunction Device Market, US, 2018 – 2028
  • Figure 14-3: Malleable Erectile Dysfunction Device Market, US, 2018 – 2028
  • Figure 14-4: Vacuum Erection Device Market, US, 2018 – 2028
  • Figure 14-5: Testicular Implant Market, US, 2018 – 2028
  • Figure 14-6: Leading Competitors, Men’s Reproductive Health Market, US, 2021
  • Figure 15-1: Urinary Guidewire Market, US, 2018 – 2028
  • Figure 15-2: Leading Competitors, Urinary Guidewire Market, US, 2021

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology